Markets:

Overview

News

Currencies

International

Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

5.445 +0.035 (+0.65%)

Streaming Delayed Price Updated: 12:17 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Savara, Inc. - Common Stock

< Previous 1 2 Next >

What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline ↗

June 27, 2026

This clinical-stage biotech focused on rare lung diseases reported significant insider selling amid a year of strong share gains.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge ↗

May 23, 2026

This biotech firm develops therapies for urothelial cancers, leveraging proprietary delivery technology and a growing clinical pipeline.

Via The Motley Fool

Topics Regulatory Compliance

Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally ↗

May 23, 2026

Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.

Via The Motley Fool

SVRA Stock Earnings: Savara Misses EPS for Q2 2024 ↗

August 12, 2024

SVRA stock results show that Savara missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

SVRA Stock Earnings: Savara Misses EPS for Q1 2024 ↗

May 09, 2024

SVRA stock results show that Savara missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

VR Adviser Adds Over 1 Million Savara Shares ↗

March 15, 2026

This clinical-stage biotech develops inhaled therapies for rare respiratory diseases, with its lead candidate in Phase III trials.

Via The Motley Fool

Topics Regulatory Compliance

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗

February 20, 2026

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

Via Stocktwits

Topics Intellectual Property Lawsuit

Get insights into the top gainers and losers of Friday's after-hours session. ↗

February 20, 2026

Via Chartmill

SVRA Stock Earnings: Savara Beats EPS for Q4 2023 ↗

March 07, 2024

SVRA stock results show that Savara beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

What's going on in today's pre-market session ↗

January 02, 2026

Via Chartmill

This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

May 29, 2025

Via Benzinga

Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday? ↗

May 27, 2025

Savara's Molbreevi BLA for autoimmune PAP was rejected by the FDA due to incomplete CMC data; the company plans to resubmit in Q4 2025.

Via Benzinga

Here are the top movers in Tuesday's session. ↗

May 27, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 27, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Surges Over 600 Points; US Durable Goods Orders Fall in April ↗

May 27, 2025

Via Benzinga

Topics Stocks

There are notable gap-ups and gap-downs in today's session. ↗

May 27, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings ↗

May 27, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

May 27, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

September 09, 2024

Via Benzinga

Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday? ↗

June 26, 2024

Savara announces Phase 3 IMPALA-2 trial results for molgramostim in treating autoimmune pulmonary alveolar proteinosis. The inhaled GM-CSF met primary and secondary endpoints, showing significant...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!

Via InvestorPlace

3 Penny Stocks Poised for Major Upside Over the Next 5 Years ↗

June 19, 2024

These three penny stocks to buy are poised for major upside over the medium-term, for various reasons worth exploring.

Via InvestorPlace

3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition ↗

June 11, 2024

Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 16, 2024

Via Benzinga

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

5 OTC Stocks With The Potential To Explode In 2024 ↗

November 08, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Via Benzinga

3 Penny Stocks to Provide 1,000% Returns Over the Next Decade ↗

September 27, 2023

Consider three intriguing penny stocks for investors looking to add a bit more risk to their portfolio in times like these.

Via InvestorPlace

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.